New study tracks asthma drug benralizumab in 1,000 chinese patients
NCT ID NCT06862206
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 36 times
Summary
This study follows 1,000 people aged 12 and older in China who have severe eosinophilic asthma and are prescribed benralizumab. Researchers will track how well the drug controls asthma symptoms over 56 weeks using patient questionnaires. The goal is to understand real-world treatment response and reasons for stopping or switching therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAnhui, China
-
Research Site
RECRUITINGAnning, China
-
Research Site
RECRUITINGBeijing, China
-
Research Site
RECRUITINGBinzhou, China
-
Research Site
RECRUITINGChangzhou, China
-
Research Site
RECRUITINGFenyang, China
-
Research Site
RECRUITINGGuangdong, China
-
Research Site
RECRUITINGGuangzhou, China
-
Research Site
RECRUITINGHangzhou, China
-
Research Site
RECRUITINGHuzhou, China
-
Research Site
RECRUITINGJiaxing, China
-
Research Site
RECRUITINGJinan, China
-
Research Site
RECRUITINGJinhua, China
-
Research Site
RECRUITINGJining, China
-
Research Site
RECRUITINGJiyuan, China
-
Research Site
RECRUITINGKunshan, China
-
Research Site
RECRUITINGLinyi, China
-
Research Site
RECRUITINGMianyang, China
-
Research Site
RECRUITINGNanbu, China
-
Research Site
RECRUITINGNanchang, China
-
Research Site
RECRUITINGNanjing, China
-
Research Site
RECRUITINGNingbo, China
-
Research Site
RECRUITINGShanghai, China
-
Research Site
RECRUITINGShanxi, China
-
Research Site
RECRUITINGShenzhen, China
-
Research Site
RECRUITINGShijiazhuang, China
-
Research Site
RECRUITINGSuining, China
-
Research Site
RECRUITINGTaiyuan, China
-
Research Site
RECRUITINGWeifang, China
-
Research Site
RECRUITINGWuhan, China
-
Research Site
RECRUITINGWuxi, China
-
Research Site
RECRUITINGXi'an, China
-
Research Site
RECRUITINGXiamen, China
-
Research Site
RECRUITINGZhangjiagang, China
-
Research Site
RECRUITINGZhengzhou, China
-
Research Site
RECRUITINGZhenjiang, China
Conditions
Explore the condition pages connected to this study.